Enanta Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Enanta Pharmaceuticals Inc
TickerENTA
CIK #0001177648
CUSIP29251M106
SectorLife Sciences - Pharmaceutical Preparations
Address500 Arsenal Street, Watertown, MA 02472
Source [EDGAR]
CIK Filing 2011 - 2024
[0001177648] 10-K
[0001177648] 10-Q
[0001177648] 3
[0001177648] 4
[0001177648] 8-K
[0001177648] SC 13D
[0001177648] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Armistice Capital LLC Enanta Pharmaceuticals Inc [2023-02-14] 0.99
BlackRock Inc Enanta Pharmaceuticals Inc [2023-01-31] 18.0
First Manhattan Co Enanta Pharmaceuticals Inc [2022-02-15] 5.46
Armistice Capital LLC Enanta Pharmaceuticals Inc [2021-02-16] 6.7
Renaissance Technologies LLC Enanta Pharmaceuticals Inc [2021-02-10] 5.13
State Street Corp Enanta Pharmaceuticals Inc [2021-02-09] 5.84
BlackRock Inc Enanta Pharmaceuticals Inc [2021-01-25] 17.0
Farallon Capital Management LLC Enanta Pharmaceuticals Inc [2019-09-27] 1.1
Price T Rowe Associates Inc /MD/ Enanta Pharmaceuticals Inc [2019-02-14] 5.5
Vanguard Group Inc Enanta Pharmaceuticals Inc [2019-02-11] 7.85
LULY Jay R Enanta Pharmaceuticals Inc [2019-01-18] 5.0
Farallon Capital Management LLC Enanta Pharmaceuticals Inc [2018-05-10] 1.1
First Manhattan Co Enanta Pharmaceuticals Inc [2018-02-09] 6.31
First Manhattan Co Enanta Pharmaceuticals Inc [2018-02-09] 6.31
Krensavage Asset Management LLC Enanta Pharmaceuticals Inc [2017-02-15] 4.6
Apex Capital Management Enanta Pharmaceuticals Inc [2016-02-10] 5.0
BlackRock Inc Enanta Pharmaceuticals Inc [2016-01-28] 8.9
Consonance Capital Management LP Enanta Pharmaceuticals Inc [2015-02-17] 0.1
Eagle Asset Management Inc Enanta Pharmaceuticals Inc [2015-01-07] 5.96
Dworsky Alan J Enanta Pharmaceuticals Inc [2014-09-18] 5.4
RA Capital Management LLC Enanta Pharmaceuticals Inc [2014-04-01] 8.0
TVM V Life Science Ventures GmbH & Co KG Enanta Pharmaceuticals Inc [2014-02-14] 14.1
FMR LLC Enanta Pharmaceuticals Inc [2014-02-14] 0.0
MRNA - Holdings LLC Enanta Pharmaceuticals Inc [2014-02-13] 0.1
AbbVie Inc Enanta Pharmaceuticals Inc [2014-02-07] 5.97
Shionogi & Co Ltd Enanta Pharmaceuticals Inc [2014-01-29] 8.9
HBM Healthcare Investments Cayman Ltd Enanta Pharmaceuticals Inc [2013-04-03] 8.69
Form 3/4/5 Filer 2011 - 2024
Enanta Pharmaceuticals Inc
Gardiner Nathaniel S.
Or Yat Sun
Mellett Paul J
Vance Terry
Luly Jay R.
Carter Bruce L A
Russell Lesley
Peterson Kristine
Hata Yujiro S
Foletta Mark G
Luu Brendan
Kieffer Tara Lynn
Rottinghaus Scott T.
Adda Nathalie
Golumbeski George
Buckley Stephen Jr.
Ocain Tim
Afting Ernst-Guenter
Fischer Stefan
TVM Medical Ventures GmbH & Co KG
Schuhsler Helmut
TVM Capital GmbH
TVM IV Management GmbH & Co. KG
TVM V Life Science Ventures GmbH & Co KG
TVM V Life Science Ventures Management GmbH & Co. KG
Goll Alexandra
Birner Hubert
TVM IV GmbH & Co KG
Goldberg Marc E.
Saints Capital Granite LP
OBP III - Holdings LLC
mRNA - Holdings LLC
OBP (Adjunct) III - Holdings LLC
Saints Capital Granite, LLC
OBP (Bermuda) III - Holdings LLC
Shionogi & Co Ltd
Verdine Gregory L.
Poorvin David
Form 13F Holdings
Firm Period DFND Voting Shares
BlackRock Inc. [2023-03-31] SOLE 3,692,239.0 3,775,353.0
Armistice Capital LLC [2023-03-31] SOLE 2,012,000.0 2,012,000.0
Farallon Capital Management LLC [2023-03-31] OTR 1,550,000.0 1,550,000.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 1,500,967.0
State Street Corp [2023-03-31] DFND 1,150,899.0 1,200,936.0
Braidwell LP [2023-03-31] SOLE 1,038,310.0 1,038,310.0
Krensavage Asset Management LLC [2023-03-31] SOLE 603,301.0 603,301.0
Northern Trust Corp [2023-03-31] OTR 213,256.0 514,849.0
Dimensional Fund Advisors LP [2023-03-31] SOLE 485,526.0 512,808.0
Renaissance Technologies LLC [2023-03-31] SOLE 413,600.0 427,464.0
Geode Capital Management LLC [2023-03-31] DFND 395,076.0 395,076.0
Citadel Advisors LLC [2023-03-31] DFND 348,757.0 348,757.0
Northern Trust Corp [2023-03-31] DFND 144,161.0 348,467.0
Jacobs Levy Equity Management Inc [2023-03-31] SOLE 302,093.0 346,455.0
Invesco Ltd. [2023-03-31] DFND 0.0 301,770.0
UBS Asset Management Americas Inc [2023-03-31] SOLE 249,378.0 275,951.0
Pictet Asset Management Sa [2023-03-31] DFND 1.0 270,853.0
First Manhattan Co LLC [2023-03-31] SOLE 253,975.0 263,375.0
Goldman Sachs Group Inc [2023-03-31] DFND 219,690.0 230,090.0
Bank of America Corp /DE/ [2023-03-31] DFND 4,458.0 222,708.0
Commodore Capital LP [2023-03-31] SOLE 217,253.0 217,253.0
Bank of New York Mellon Corp [2023-03-31] DFND 155,226.0 167,703.0
JPMorgan Chase & Co [2023-03-31] DFND 123,153.0 167,179.0
Price T Rowe Associates Inc /MD/ [2023-03-31] SOLE 33,414.0 154,343.0
Charles Schwab Investment Management Inc [2023-03-31] SOLE 148,558.0 148,558.0
Millennium Management LLC [2023-03-31] SOLE 140,783.0 140,783.0
Morgan Stanley [2023-03-31] DFND 118,240.0 131,948.0
Principal Financial Group Inc [2023-03-31] DFND 121,603.0 121,603.0
FMR LLC [2023-03-31] DFND 119,766.0 120,101.0
Assenagon Asset Management S.A. [2023-03-31] SOLE 118,357.0 118,357.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com